Unicycive Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -1.86 | -100% |
| P/S |
|
21.09 | 33.76 | -37.54% |
|
|
| P/BV |
|
-3.74 | 4.82 | -177.51% |
|
|
| P/FCF |
|
-2.32 | 61 | -103.8% |
|
|
| Ev/Ebitda |
|
-0.2608 | -22.15 | -98.82% |
|
|
| Ev/S |
|
7.92 | 22.56 | -64.92% |
|
|
| Ev/FCF |
|
-0.292 | 68.78 | -100.42% |
|
|
| E/P |
|
-0.7204 | 0.0178 | -4153.18% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-3035.56 | 4.98 | -61092.42% | -3176.05 | -4.42% |
| ROE |
|
801.89 | 9.61 | 8242.96% |
|
|
| ROA |
|
-215.24 | 0.3443 | -62621.16% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-4525.04 | -25.17 | 17877.83% |
|
|
| ROCE |
|
545.39 | 15.35 | 3452.97% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0396 | -3.68 | -98.92% | -0.2708 | -85.38% |
| Nеt Debt/Ebitda |
|
0.4339 | -3.44 | -112.62% |
|
|
| Debt/Ratio |
|
0.0571 | 0.1985 | -71.21% |
|
|
| Debt/Equity |
|
0.3119 | 1.66 | -81.23% |
|
|
| Debt/Net Income |
|
-0.0266 | 10.32 | -100.26% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5468 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.2632 | -100% | ||
| DSI |
|
0 | 0.2193 | -100% |
|
|
| Average dividend growth |
|
0 | 0.4414 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4968 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5468 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-29.02 | -56.89 | -48.99% | ||
| Growth impulse Ebitda in 5 years |
|
1408.9 | -54.68 | -2676.63% | ||
| Growth impulse Net Income in 5 years |
|
1288.36 | -58.33 | -2308.74% | ||
| Growth impulse FCF in 5 years |
|
1424.58 | -49.48 | -2979.1% | ||
| Growth impulse EPS in 5 years |
|
709.82 | -32.41 | -2290.13% |
IP Score
5.02/10
